Gilead knew Hepatitis drug price was high, Senate says By: MarketWatch December 01, 2015 at 16:30 PM EST Company understood price would put treatment out of reach for many patients, report concludes. Read More >> Related Stocks: Gilead Sciences Valeant Pharmaceuticals International, Inc.